Zongsheng Guo

659 total citations
25 papers, 518 citations indexed

About

Zongsheng Guo is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Zongsheng Guo has authored 25 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 9 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Zongsheng Guo's work include Acute Myocardial Infarction Research (5 papers), DNA Repair Mechanisms (4 papers) and Polyomavirus and related diseases (4 papers). Zongsheng Guo is often cited by papers focused on Acute Myocardial Infarction Research (5 papers), DNA Repair Mechanisms (4 papers) and Polyomavirus and related diseases (4 papers). Zongsheng Guo collaborates with scholars based in China, United States and Switzerland. Zongsheng Guo's co-authors include Melvin L. DePamphilis, Crisanto Gutiérrez, James Y. Yang, Lei Zhao, Meili Zheng, Tao Wang, Zheng Ma, Kuibao Li, Xinchun Yang and Richard J. Roberts and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Zongsheng Guo

25 papers receiving 507 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zongsheng Guo China 13 301 126 101 89 50 25 518
Susmita Chakrabarti United States 16 529 1.8× 149 1.2× 187 1.9× 102 1.1× 92 1.8× 20 891
Jiao Yang China 16 319 1.1× 182 1.4× 69 0.7× 62 0.7× 63 1.3× 57 617
Saiful A. Mir United States 10 306 1.0× 131 1.0× 127 1.3× 58 0.7× 58 1.2× 17 523
Alexandra Vayl United States 5 313 1.0× 54 0.4× 81 0.8× 41 0.5× 30 0.6× 6 490
Doris R. Powell United States 13 543 1.8× 148 1.2× 51 0.5× 111 1.2× 133 2.7× 16 887
Hideyuki Higashi United States 12 287 1.0× 99 0.8× 217 2.1× 147 1.7× 64 1.3× 24 693
Kenichi Fujise United States 12 313 1.0× 53 0.4× 69 0.7× 121 1.4× 69 1.4× 25 557
Tianjiao Sun United States 10 288 1.0× 64 0.5× 36 0.4× 74 0.8× 39 0.8× 15 479
David Ridinger United States 12 163 0.5× 87 0.7× 131 1.3× 34 0.4× 92 1.8× 17 459

Countries citing papers authored by Zongsheng Guo

Since Specialization
Citations

This map shows the geographic impact of Zongsheng Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zongsheng Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zongsheng Guo more than expected).

Fields of papers citing papers by Zongsheng Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zongsheng Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zongsheng Guo. The network helps show where Zongsheng Guo may publish in the future.

Co-authorship network of co-authors of Zongsheng Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Zongsheng Guo. A scholar is included among the top collaborators of Zongsheng Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zongsheng Guo. Zongsheng Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Guo, Zongsheng, et al.. (2023). Declined plasma microfibrillar-associated protein 4 levels in acute coronary syndrome. European journal of medical research. 28(1). 32–32. 2 indexed citations
3.
Fu, Yuan, Hao Sun, Kun Zuo, et al.. (2022). Patients with end-stage renal disease requiring hemodialysis benefit from percutaneous coronary intervention after non-ST-segment elevation myocardial infarction. Internal and Emergency Medicine. 17(4). 1087–1095. 3 indexed citations
4.
Zhang, Yeping, Zongsheng Guo, Zheng Ma, et al.. (2022). Elevated Plasma Thymic Stromal Lymphopoietin After Acute Myocardial Infarction. Frontiers in Cardiovascular Medicine. 9. 685677–685677. 2 indexed citations
5.
Sun, Hao, Xinchun Yang, Meili Zheng, et al.. (2022). Nerve growth factor protects against cadmium-induced hypertension in mice via vascular remodeling. Tropical Journal of Pharmaceutical Research. 20(7). 1419–1424. 1 indexed citations
6.
Wang, Lefeng, Lihong Liu, Xinchun Yang, et al.. (2021). Impact of Prior Digestive System Disease on In-Hospital Gastrointestinal Bleeding in Patients with Acute Myocardial Infarction. Risk Management and Healthcare Policy. Volume 14. 1233–1239. 2 indexed citations
7.
Fu, Yuan, Hao Sun, Zongsheng Guo, et al.. (2020). A risk score model to predict in-hospital mortality of patients with end-stage renal disease and acute myocardial infarction. Internal and Emergency Medicine. 16(4). 905–912. 6 indexed citations
8.
Fu, Yuan, Mulei Chen, Hao Sun, et al.. (2020). Blood group A: a risk factor for heart rupture after acute myocardial infarction. BMC Cardiovascular Disorders. 20(1). 471–471. 2 indexed citations
9.
Zhao, Lei, Zongsheng Guo, Pan Wang, et al.. (2019). Proteomics of epicardial adipose tissue in patients with heart failure. Journal of Cellular and Molecular Medicine. 24(1). 511–520. 47 indexed citations
10.
11.
Zhao, Lei, Meili Zheng, Zongsheng Guo, et al.. (2019). Circulating Serpina3 levels predict the major adverse cardiac events in patients with myocardial infarction. International Journal of Cardiology. 300. 34–38. 24 indexed citations
12.
Zhao, Lei, Zheng Ma, Zongsheng Guo, et al.. (2019). Analysis of long non-coding RNA and mRNA profiles in epicardial adipose tissue of patients with atrial fibrillation. Biomedicine & Pharmacotherapy. 121. 109634–109634. 41 indexed citations
13.
Guo, Zongsheng, Xinchun Yang, Mulei Chen, et al.. (2015). Impact of Cardiogenic Vomiting in Patients with STEMI: A Study From China. Medical Science Monitor. 21. 3792–3797. 2 indexed citations
14.
Ye, Gengtai, Jun Zhang, Linpei Wang, et al.. (2012). miR-574-5p negatively regulates Qki6/7 to impact β-catenin /Wnt signalling and the development of colorectal cancer. Gut. 62(5). 716–726. 102 indexed citations
15.
Wang, Tao, Yu Luo, Qiao Wu, et al.. (2011). Aldo-keto reductase-7A protects liver cells and tissues from acetaminophen-induced oxidative stress and hepatotoxicity. Hepatology. 54(4). 1322–1332. 45 indexed citations
16.
Qiu, Longxin, Xiaochun Wu, Jenny Chau, et al.. (2008). Aldose Reductase Regulates Hepatic Peroxisome Proliferator-activated Receptor α Phosphorylation and Activity to Impact Lipid Homeostasis. Journal of Biological Chemistry. 283(25). 17175–17183. 47 indexed citations
17.
Tong, Xiaowen, Dirk G. Engehausen, Irina U. Agoulnik, et al.. (1998). The efficacy of adenovirus-mediated gene therapy of ovarian cancer is enhanced by using the cytomegalovirus promoter.. PubMed. 18(2A). 719–25. 13 indexed citations
18.
Gutiérrez, Crisanto, et al.. (1990). Simian Virus 40 Origin Auxiliary Sequences Weakly Facilitate T-Antigen Binding but Strongly Facilitate DNA Unwinding. Molecular and Cellular Biology. 10(4). 1719–1728. 9 indexed citations
19.
Guo, Zongsheng, et al.. (1989). Origin Auxiliary Sequences Can Facilitate Initiation of Simian Virus 40 DNA Replication In Vitro as They Do In Vivo. Molecular and Cellular Biology. 9(9). 3593–3602. 29 indexed citations
20.
Guo, Zongsheng, et al.. (1987). Initiation of simian virus 40 DNA replicationin vitro:identification of RNA-Primed nascent DNA chains. Nucleic Acids Research. 15(19). 7877–7888. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026